Biological markers in the diagnosis and treatment of ALS

[1]  M. Gurney,et al.  Relationship of oxygen radical‐induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS , 1998, Journal of neuroscience research.

[2]  F Träber,et al.  Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. , 1998, Archives of neurology.

[3]  D. Arnold,et al.  Recovery of N‐acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy , 1998, Neuroreport.

[4]  M. Gaweł,et al.  Effect of recombinant human insulin-like growth factor-I on progression of ALS , 1997, Neurology.

[5]  P M Matthews,et al.  Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy , 1997, Neurology.

[6]  W. Paulus,et al.  Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis , 1997, Neurology.

[7]  Robert H. Brown,et al.  Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.

[8]  M. Gurney,et al.  Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.

[9]  K. Mills,et al.  Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis , 1997, Muscle & nerve.

[10]  G. Parry,et al.  Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis , 1996, Neurology.

[11]  S. Budd,et al.  Mitochondria, Calcium Regulation, and Acute Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells , 1996, Journal of neurochemistry.

[12]  A. Doble.  The pharmacology and mechanism of action of riluzole , 1996, Neurology.

[13]  P N Leigh,et al.  Excitotoxicity in ALS , 1996, Neurology.

[14]  B. Pakkenberg,et al.  Muscarinic, N-methyl-d-aspartate (NMDA) and benzodiazepine receptor binding sites in cortical membranes from amyotrophic lateral sclerosis patients , 1996, Journal of the Neurological Sciences.

[15]  A. F. Schinder,et al.  Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.

[16]  I. Reynolds,et al.  Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.

[17]  A. Ludolph,et al.  Toxic models of upper motor neuron disease , 1996, Journal of the Neurological Sciences.

[18]  P. Andres,et al.  A comparison of three measures of disease progression in ALS , 1996, Journal of the Neurological Sciences.

[19]  M. Harada,et al.  Effectiveness of revascularization surgery evaluated by proton magnetic resonance spectroscopy and single photon emission computed tomography. , 1996, Neurologia medico-chirurgica.

[20]  Peter M. G. Munro,et al.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.

[21]  P. Leigh,et al.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.

[22]  A Eisen,et al.  Cortical projections to spinal motoneurons , 1996, Neurology.

[23]  M. Hediger,et al.  Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate , 1996, Neuron.

[24]  M. Gurney,et al.  Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[25]  A. Yagishita.  [MR imaging of the brain of amyotrophic lateral sclerosis]. , 1995, Rinsho shinkeigaku = Clinical neurology.

[26]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[27]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[28]  C. Allen,et al.  The neurotoxin, β-N-methylamino-l-alanine (BMAA) interacts with the strychnine-insensitive glycine modulatory site of the N-methyl-d-aspartate receptor , 1995, Neuropharmacology.

[29]  P. Ince,et al.  CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[30]  F. Kerling,et al.  Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis , 1995, Journal of the Neurological Sciences.

[31]  J. Belleroche,et al.  Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA , 1995, Brain Research.

[32]  H Feistner,et al.  Comparison of single motor unit responses to transcranial magnetic and peroneal nerve stimulation in the tibialis anterior muscle of patients with amyotrophic lateral sclerosis. , 1995, Electroencephalography and clinical neurophysiology.

[33]  B D Ross,et al.  Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. , 1995, The Journal of clinical investigation.

[34]  M. Beal.  Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases , 1995 .

[35]  J. Rothstein.  Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. , 1995, Advances in neurology.

[36]  M. Gaweł,et al.  Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. , 1995, Radiology.

[37]  D. Arnold,et al.  Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo , 1994, Neurology.

[38]  B. Ross,et al.  Brief report: organic osmolytes in the brain of an infant with hypernatremia. , 1994, The New England journal of medicine.

[39]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[40]  Richard S. J. Frackowiak,et al.  Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis , 1994, Neurology.

[41]  J. Urenjak,et al.  Extracellular N‐Acetylaspartate in the Rat Brain: In Vivo Determination of Basal Levels and Changes Evoked by High K+ , 1994, Journal of neurochemistry.

[42]  V. Meininger,et al.  A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.

[43]  D. Arnold,et al.  Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images , 1994, Annals of neurology.

[44]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[45]  P. M. Matthews,et al.  Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies , 1993, Neurology.

[46]  K. Ohtomo,et al.  Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. , 1993, Radiology.

[47]  M. Pericak-Vance,et al.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.

[48]  F. Segawa.  [MR findings of the pyramidal tract in amyotrophic lateral sclerosis]. , 1993, Rinsho shinkeigaku = Clinical neurology.

[49]  J. Rothstein,et al.  Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  B. Hyman,et al.  Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? , 1993, Trends in Neurosciences.

[51]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[52]  J. Rothstein,et al.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.

[53]  A. Lajtha,et al.  Decreased brain N-acetylaspartate in Huntington's disease , 1992, Brain Research.

[54]  J. Coyle,et al.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.

[55]  Mb Alan J. McComas Dr.,et al.  The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis. , 1991 .

[56]  J. Neale,et al.  Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.

[57]  D. Menon,et al.  Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. , 1990, Journal of computer assisted tomography.

[58]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[59]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[60]  R. Zatorre,et al.  Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. , 1990, The New England journal of medicine.

[61]  J. Shapiro,et al.  Effects of hypernatremia on organic brain osmoles. , 1990, The Journal of clinical investigation.

[62]  K Sartor,et al.  Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings. , 1989, Radiology.

[63]  J. Frahm,et al.  Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.

[64]  H. Durham,et al.  A hypothesis for the pathogenesis of amyotrophic lateral sclerosis. , 1988, Revue neurologique.

[65]  J. Neale,et al.  Immunohistochemistry and Biosynthesis of N‐Acetylaspartylglutamate in Spinal Sensory Ganglia , 1987, Journal of neurochemistry.

[66]  G. Smith,et al.  A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience , 1987, Annals of neurology.

[67]  M. Brownstein,et al.  N‐Acetylation of L‐Aspartate in the Nervous System: Differential Distribution of a Specific Enzyme , 1985, Journal of neurochemistry.

[68]  J. Coyle,et al.  N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.

[69]  T. Patel,et al.  Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. , 1979, The Biochemical journal.

[70]  E. Dicker,et al.  A RELATIONSHIP OF N‐ACETYLASPARTATE BIOSYNTHESIS TO NEURONAL PROTEIN SYNTHESIS 1 2 , 1975, Journal of neurochemistry.

[71]  D'Adamo Af,et al.  Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. , 1968 .